Now showing items 1-1 of 1
Evaluation of novel diagnostic and therapeutic modalities for treatment of canine pulmonary hypertension
(University of Missouri--Columbia, 2008)
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Pimobendan, a phosphodiesterase III inhibitor and calcium channel sensitizing agent, was hypothesized to decrease the severity of pulmonary hypertension ...